ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB106

Dialysis and Survival in Advanced CKD

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Pickthorn, Sean, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States
  • Reule, Scott, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States
  • Ishani, Areef, University of Minnesota Twin Cities, Minneapolis, Minnesota, United States
  • Foley, Robert N., University of Minnesota Twin Cities, Minneapolis, Minnesota, United States
Background

The decision to initiate dialysis in advanced, but stable, chronic kidney disease is difficult to navigate and can benefit from population level data on longevity.

Methods

We evaluated dialysis-naïve subjects with estimated glomerular filtration rate (eGFR) < 15 mL/min/1.73m2 on at least 2 occasions between 90 and 365 days apart (n = 86,293). Individuals initiating dialysis (cases) were matched with those not initiating dialysis (controls) on the same day and with the same baseline propensity to start dialysis, with survival evaluated from that day forward.

Results

In our study population, 48.5% were ≥ 70 years and the eGFR distribution was <5 mL/min/1.73m2 (5.7%), 5.0-9.9 (28.3%) and 10-14.9 (66.1%). Approximately half (45.4%) of the study population began maintenance dialysis after a median follow-up of 1.7 years. Overall median survival times were 2.89 (CI [95% confidence interval] 2.66-3.16) years in cases and 1.26 (CI 1.20-1.32) years in controls (hazards ratio 0.68 [0.63-0.73], P-Value < 0.001). Initiating dialysis was associated with an increase in median survival of 1.63 (CI 1.40-1.90) years. Dialysis-associated survival increments were 3.15 (CI 2.28-5.36) years with eGFR < 5, 1.64 (CI 1.11-2.10) years with eGFR 5 to 9.9, and 1.55 (CI 1.24-1.90) years with eGFR 10 to 14.9 mL/min/1.73m2. Dialysis was associated with positive survival increments in all age groups except those ≥ 90 years.

Conclusion

In a population with eGFR chronically below 15 mL/min/1.73m2, dialysis was associated with meaningful survival increases.

Funding

  • Veterans Affairs Support

Digital Object Identifier (DOI)